Repligen Corp.
RGEN
Market Cap$8.99B
Close$
$71.69
57.3% downside
Current Fair Value
57.3% downsideOvervalued by 57.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $8.99 Billion |
|---|---|
| Enterprise Value | $8.88 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $0.64 |
| Beta | 0.96 |
| Outstanding Shares | 56,013,038 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -433.77 |
|---|---|
| PEG | - |
| Price to Sales | 16.79 |
| Price to Book Ratio | 4.66 |
| Enterprise Value to Revenue | 14.42 |
| Enterprise Value to EBIT | -404.37 |
| Enterprise Value to Net Income | -4673 |
| Total Debt to Enterprise | 0.08 |
| Debt to Equity | 0.33 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Repligen Corp.
CEO: Anthony Hunt